Prevalence of Asthma and Allergies Among Children in UAE
NCT ID: NCT03878680
Last Updated: 2020-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3737 participants
OBSERVATIONAL
2019-04-30
2019-06-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE. A Descriptive Analysis of the Asthma Patient Population in the Emirate of Dubai With Respect to Healthcare Resource Utilization, Costs, and Asthma-related Treatment Pattern
NCT03963141
Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population
NCT02153411
A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms
NCT00986219
National Survey on Asthma
NCT00770250
Achieving Control of Asthma in Children In Africa
NCT03990402
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ISAAC Questionnaires
1. Core questionnaire on wheezing.
2. Core questionnaire on rhinitis.
3. Core questionnaire on atopic dermatitis.
4. Smoking questions of the environmental questionnaire.
5. Video questionnaire on wheezing (only for 13-14 years age group, if applicable)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
13-14 years age group
Children with age 13-14 years at the time of questionnaires completion, and residing in Dubai and the Northern Emirates of UAE.
Study questionnaires
Completion of the International study of Asthma and Allergies in Children(ISAAC)core questionnaires:
1. Core questionnaire on wheezing.
2. Core questionnaire on rhinitis.
3. Core questionnaire on atopic dermatitis.
6-7 years age goup
Children with age 6-7 years at the time of questionnaires completion, and residing in Dubai and the Northern Emirates of UAE.
Study questionnaires
Completion of the International study of Asthma and Allergies in Children(ISAAC)core questionnaires:
1. Core questionnaire on wheezing.
2. Core questionnaire on rhinitis.
3. Core questionnaire on atopic dermatitis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Study questionnaires
Completion of the International study of Asthma and Allergies in Children(ISAAC)core questionnaires:
1. Core questionnaire on wheezing.
2. Core questionnaire on rhinitis.
3. Core questionnaire on atopic dermatitis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children aged 6 to 7 years or 13 to14 years, whose legal guardians give their consent.
* Able to give assent in the 13 to 14 years group.
* Able to comprehend and answer the questionnaire themselves in the 13 to 14 years group.
Exclusion Criteria
* Parent or legal guardian refuses sign and return consent for the 6 to 7 years group and the 13 to 14 years group.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Ajman, , United Arab Emirates
Research Site
Dubai, , United Arab Emirates
Research Site
FUJ, , United Arab Emirates
Research Site
Ras al-Khaimah, , United Arab Emirates
Research Site
Sharjah city, , United Arab Emirates
Research Site
UMQ, , United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D2287R00142
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.